Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Gary S. Firestein, MD
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Ryan Quigley
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Detecting Sjögren’s Disease Early: Why Education and Awareness Matters
Nancy Carteron, MD
Sjögren’s Disease Management: A Decade in Review
Preventing Sjögren’s Complications: The Importance of Timely, Accurate Diagnosis
Sjögren’s Disease Care: Diagnosis and Management Considerations
Early Rituximab Use in Sjögren’s Syndrome: A Meta-Analysis Review
Differentiating and Diagnosing Sjögren’s-Related Dry Eye
Michelle Hessen, OD
Sjögren’s-Related Dry Eye: Examining Targeted Treatment Strategies
Assessing Adverse Pregnancy Outcomes in Isolated Sjögren’s Disease
Marlene Maeusli
Efgartigimod Shows Early Promise for Primary Sjögren’s Disease
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Laura Cappelli, MD, MHS,MS
Evolving Strategies in Lupus Care: Recent Findings and Ongoing Challenges
Michelle Kahlenberg, MD, PhD
Loading...
We're glad to see you're enjoying Rheumatology Academy… but how about a more personalized experience?
Press cancel to remain on Rheumatology Academy. Press the link below or the continue button to keep going.